2,604
Views
1
CrossRef citations to date
0
Altmetric
Pregnancy, Childbirth & Women’s Health

Augmentation index and pulse wave velocity in normotensive versus preeclamptic pregnancies: a prospective case–control study using a new oscillometric method

&
Pages 1-10 | Received 22 Jan 2021, Accepted 29 Nov 2021, Published online: 22 Dec 2021

References

  • Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM. 2002;95(2):67–74.
  • Mitchell GF, Hwang S-J, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation. 2010;121(4):505–511.
  • Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56:e50-e103.
  • Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999;281(7):634–639.
  • Doumas M, Papademetriou V, Athyros V, et al. Arterial stiffness and emerging biomarkers: still a long journey to go. Angiology. 2015;66(10):901–903.
  • Katsiki N, Athyros VG, Karagiannis A, et al. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol. 2014;12(4):627–641.
  • Zanoli L, Lentini P, Briet M, et al. Arterial stiffness in the heart disease of CKD. J Am Soc Nephrol. 2019;30(6):918–928.
  • Chirinos JA, Segers P, Hughes T, et al. Large-artery stiffness in health and disease: JACC state-of-the-art review . J Am Coll Cardiol. 2019;74(9):1237–1263.
  • Wilkinson IB, MacCallum H, Flint L, et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol. 2000;525(1):263–270.
  • Baulmann J, Schillings U, Rickert S, et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens. 2008;26(3):523–528.
  • Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail. 2019;21(4):402–424.
  • Ray JG, Vermeulen MJ, Schull MJ, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet Lond Engl. 2005;366(9499):1797–1803.
  • Brown MA, Magee LA, International Society for the Study of Hypertension in Pregnancy (ISSHP), et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.
  • Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2020.DOI:10.106/j.ajog.2020.08.045
  • ACOG. Practice bulletin no. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:e1–e25.
  • Roberts JM, Pearson G, Cutler J, et al. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertens Dallas Tex 1979. 2003;41:437–445.
  • Smith DD, Costantine MM. The role of statins in the prevention of preeclampsia. Am J Obstet Gynecol. 2020.DOI:10.106/j.ajog.2020.08.040
  • Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull. 2003;67:161–176.
  • Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1–544.e12.
  • Irgens HU, Reisaeter L, Irgens LM, et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323(7323):1213–1217.
  • Yu CKH, Khouri O, for The Fetal Medicine Foundation Second-Trimester Screening Group, et al. Prediction of pre-eclampsia by uterine artery doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol. 2008;31(3):310–313.
  • Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet Lond Engl. 2001;357(9249):53–56.
  • Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393–2398.
  • Greer IA. Thrombosis in pregnancy: updates in diagnosis and management. Hematol Am Soc Hematol Educ Program. 2012;2012:203–207.
  • Chappell LC, Enye S, Seed P, et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertens Dallas Tex 1979. 2008;51(4):1002–1009.
  • McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918–930.
  • Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56(1):166–171.
  • Hausvater A, Giannone T, Sandoval Y-HG, et al. The association between preeclampsia and arterial stiffness. J Hypertens. 2012;30(1):17–33.
  • Namugowa A, Iputo J, Wandabwa J, et al. Comparison of arterial stiffness in preeclamptic and normotensive pregnant women from a semi-rural region of South Africa. Clin Exp Hypertens N Y N 1993. 2017;39(3):277–283.
  • Torrado J, Farro I, Zócalo Y, et al. Preeclampsia is associated with increased central aortic pressure, elastic arteries stiffness and wave reflections, and resting and recruitable endothelial dysfunction. Int J Hypertens. 2015;2015:720683.
  • Osman MW, Nath M, Breslin E, et al. Association between arterial stiffness and wave reflection with subsequent development of placental-mediated diseases during pregnancy: findings of a systematic review and meta-analysis. J Hypertens. 2018;36(5):1005–1014.
  • Kim S, Lim HJ, Kim J-R, et al. Longitudinal change in arterial stiffness after delivery in women with preeclampsia and normotension: a prospective cohort study. BMC Pregnancy Childbirth. 2020;20(1):685. [Internet]. [cited 2021 Apr 4]Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661192/.
  • Robb AO, Mills NL, Din JN, et al. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertens Dallas Tex 1979. 2009;53(6):952–958.
  • Elvan-Taşpinar A, Bots ML, Franx A, et al. Stiffness of the arterial wall, joints and skin in women with a history of pre-eclampsia. J Hypertens. 2005;23(1):147–151.
  • Lampinen KH, Rönnback M, Kaaja RJ, et al. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006;24(4):751–756.
  • Rönnback M, Lampinen K, Groop P-H, et al. Pulse wave reflection in currently and previously preeclamptic women. Hypertens Pregnancy. 2005;24(2):171–180.
  • Pàez O, Alfie J, Gorosito M, et al. Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of pre-eclampsia. Clin Exp Hypertens N Y N 1993. 2009;31(7):544–552.
  • Oyama-Kato M, Ohmichi M, Takahashi K, et al. Change in pulse wave velocity throughout normal pregnancy and its value in predicting pregnancy-induced hypertension: a longitudinal study. Am J Obstet Gynecol. 2006;195(2):464–469.
  • Franz MB, Burgmann M, Neubauer A, et al. Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies. Acta Obstet Gynecol Scand. 2013;92(8):960–966.
  • Kalafat E, Thilaganathan B. Cardiovascular origins of preeclampsia. Curr Opin Obstet Gynecol. 2017;29(6):383–389.
  • Carty DM, Neisius U, Rooney LK, et al. Pulse wave analysis for the prediction of preeclampsia. J Hum Hypertens. 2014;28(2):98–104.
  • Thadhani R, Ecker JL, Kettyle E, et al. Pulse pressure and risk of preeclampsia: a prospective study. Obstet Gynecol. 2001;97(4):515–520.
  • Cooper KM, Barrett T, McBride CA, et al. Subclinical cardiac stiffness is associated with arterial stiffness in healthy young nulligravid women: potential links to preeclampsia. Pregnancy Hypertens. 2019;18:49–54.
  • Grand’Maison S, Pilote L, Okano M, et al. Markers of vascular dysfunction after hypertensive disorders of pregnancy: a systematic review and meta-analysis. Hypertens Dallas Tex 1979. 2016;68(6):1447–1458.
  • Hale SA, Badger GJ, McBride C, et al. Prepregnancy vascular dysfunction in women who subsequently develop hypertension during pregnancy. Pregnancy Hypertens. 2013;3(2):140–145.
  • Magnussen EB, Vatten LJ, Lund-Nilsen TI, et al. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335(7627):978.
  • Bellamy L, Casas J-P, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
  • Laurent S, Cockcroft J, European Network for Non-invasive Investigation of Large Arteries, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605.
  • Karamanoglu M, Gallagher DE, Avolio AP, et al. Pressure wave propagation in a multibranched model of the human upper limb. Am J Physiol. 1995;269 (4 Pt 2):H1363–H1369.
  • Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans. Am J Hypertens. 2002;15(8):743–753.
  • Pannier B, Guérin AP, Marchais SJ, et al. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 2005;45(4):592–596.
  • Oylumlu M, Oylumlu M, Yuksel M, et al. A simple method for the assessment of arterial stiffness in pre-eclamptic patients. Clin Exp Hypertens. 2014;36(8):531–537.
  • Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX–XIV.
  • Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
  • Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? Am J Obstet Gynecol. 2021.DOI:10.1016/j.ajog.2020.10.024
  • Jauniaux E, Watson AL, Hempstock J, et al. Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure. Am J Pathol. 2000;157(6):2111–2122.
  • de Alwis N, Binder NK, Beard S, et al. Novel approaches to combat preeclampsia: from new drugs to innovative delivery. Placenta. 2020;102:10–16.
  • Savvidou MD, Noori M, Anderson JM, et al. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation. Ultrasound Obstet Gynecol. 2008;32(7):871–876.
  • Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31(1):66–74.
  • Khalil A, Maiz N, Garcia-Mandujano R, et al. Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia. Ultrasound Obstet Gynecol off J Int Soc Ultrasound Obstet Gynecol. 2014;44:402–410.
  • Brosens I, Pijnenborg R, Vercruysse L, et al. The “ "Great Obstetrical Syndromes" are associated with disorders of deep placentation”. Am J Obstet Gynecol. 2011;204(3):193–201.
  • Maynard SE, Min J-Y, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
  • Tsiakkas A, Cazacu R, Wright A, et al. Maternal serum placental growth factor at 12, 22, 32 and 36 weeks’ gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2016;47(4):472–477.
  • Tsiakkas A, Duvdevani N, Wright A, et al. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;45(5):591–598.
  • Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
  • Hamad RR, Eriksson MJ, Silveira A, et al. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens. 2007;25(11):2301–2307.
  • Yinon Y, Kingdom JCP, Odutayo A, et al. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation. 2010;122(18):1846–1853.
  • Khalil A, Cowans NJ, Spencer K, et al. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound Obstet Gynecol. 2010;35:n/a–679.
  • Olson KN, Redman LM, Sones JL. Obesity “complements” preeclampsia. Physiol Genomics. 2019;51(3):73–76.
  • Gui J, Ling Z, Hou X, et al. In vitro fertilization is associated with the onset and progression of preeclampsia. Placenta. 2020;89:50–57.